Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

SCIENION Announces Launch of sciLINER

Published: Wednesday, November 13, 2013
Last Updated: Wednesday, November 13, 2013
Bookmark and Share
Line dispenser for membrane materials with full drop formation control at Medica 2013.

SCIENION AG has announced the launch of the sciLINER, the first dispenser to print lines on membranes with full visual drop detection.

With up to four channels, a minimum dispensing volume of 0.1 µl/cm and a flow rate of up to 8 ml/min the sciLINER represents an economical entry unit enabling the production of lateral flow devices or other membrane-based materials.

With its printing speed of 20 seconds per sheet it covers production from small to medium throughput. It can be operated in either aspirate dispense or bulk dispense modes to produce continuous lines with a width from 0.5 to 5 mm.

In contrast to current technologies, the sciLINER allows for the online monitoring of drop formation and offers integrated drop volume measuring.

Both are important features when sensitive biological materials such as antigens, antibodies or DNA are deposited on substrates used in the diagnostics industry.

The non-contact dispenser loads all membranes and flat targets with a size of up to 150 x 300 mm. “This is our first product specifically geared towards the point of care testing market”, says Dr. Holger Eickhoff, CEO of SCIENION AG.

Dr. Eickhoff continued, “As with all our technologies, this new technology does not only meet present needs for R&D efforts but, with drop control mechanisms, also forms the basis for a stable production of point of care tests based on membrane materials.”

Assays on membrane materials have become a very popular and versatile test format for rapid point of care diagnostics since their introduction in the mid-1980s. All kinds of biological samples can be tested, for example blood, serum, urine and, more recently, also saliva, sweat or tears if the sensitivity of the test is sufficient.

Typically these tests, especially in so called Lateral Flow Tests such as popular pregnancy strip tests (often referred to as “dipstick tests”) combine several advantages being quick and easy to use with no specific equipment required.

Eickhoff states: “Reproducibility in R&D and production is key to develop and produce reliable diagnostic tests. We are confident that the sciLINER, offering central dispense steps monitoring and control from test development to manufacturing, will help customers shorten time to market with their diagnostic products.”

The sciLINER will be exhibited at the SCIENION booth at MEDICA 2013, November 20-23 in Düsseldorf, Germany, booth 3A42 in hall 3.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Molecular Detection of Colon Cancer
AIT, BioVendor and SCIENION signed cooperation agreement for early detection of colon cancer.
Saturday, September 27, 2014
Scientific News
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos